Effect of berberine hydrochloride-functionalized gold nanoparticles on calf thymus DNA: a biophysical study

Related Experiment Video

Updated: Aug 12, 2026

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy
10:51

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Published on: August 28, 2013

11.2K

Yong-Chang Liu1, Cheng Xu1, Wen-Wen Ren1

  • 1Hubei Key Laboratory of Pollutant Analysis & Reuse Technology, College of Chemistry and Chemical Engineering, Hubei Normal University, Huangshi, PR China.

Journal of Biomolecular Structure & Dynamics
|October 22, 2019
PubMed

Abstract:

Communicated by Ramaswamy H. Sarma.

More Related Videos

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

13.0K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.8K

Related Experiment Videos

Last Updated: Aug 12, 2026

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy
10:51

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

Published on: August 28, 2013

11.2K
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

13.0K
Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
06:06

Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles

Published on: March 9, 2019

5.8K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Articles linked to this work by shared authors, journal, and citation graph.

Revealing the effects of ligands of silver nanoclusters on the interactions between them and ctDNA: Abstraction to visualization.

International journal of biological macromolecules·2023

Structure-dependent of 3-fluorooxindole derivatives interacting with ctDNA: Binding effects and molecular docking approaches.

Bioorganic chemistry·2022

Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study.

Thoracic cancer·2021

Adenosquamous carcinoma of the breast: a population-based study.

Breast cancer (Tokyo, Japan)·2021

The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.

European journal of integrative medicine·2021

Evolving landscape and academic attitudes toward the controversies of global immuno-oncology trials.

International journal of cancer·2021

Understanding the change in calcium ion-binding, protein dynamics, and hydration behavior from the wild type for two pathogenic mutants (D3V and G34R) of troponin-C: molecular dynamics simulation and network analysis.

Journal of biomolecular structure & dynamics·2026

Interaction of serum carrier protein with anticancer drugs, PCZ and PXN on binary and ternary systems through multi-spectroscopic, molecular modeling and quantum chemical approaches.

Journal of biomolecular structure & dynamics·2026

Structure-dynamics analysis of insulin receptor modulation by plant-derived ligands suggests a potential regulatory role for Asn711.

Journal of biomolecular structure & dynamics·2026

Coarse grained molecular dynamics analysis of menthol interactions with ergosterol in a fungal mimetic membrane.

Journal of biomolecular structure & dynamics·2026

Computational analysis of pathogenic nsSNPs in the human TNF gene and their role in neuroinflammation in Adrenoleukodystrophy.

Journal of biomolecular structure & dynamics·2026

Structure-function studies of four disulfide-containing insulins from Conus textile and Conus memiae and a snail-guided human insulin analogue.

Journal of biomolecular structure & dynamics·2026

Experience with subcutaneous testosterone for gender-affirming hormone therapy in transgender men at a tertiary care center.

Endocrinologia, diabetes y nutricion·2026

[Disease modeling with iPSCs for pathophysiological elucidation and therapeutic research: establishment of an iPSC-based drug discovery platform centered on drug repositioning].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Progress and challenges in cell culture-based red blood cell production].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

A lifetime with RNA: John J. Rossi and the questions that science revisits.

Bioscience trends·2026

Second allogeneic haematopoietic stem cell transplantation for non-malignant diseases.

British journal of haematology·2026

IDH2 p.R172 mutation Predicts Superior Outcomes in IDH-mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome patients undergoing Allogeneic Hematopoietic Cell Transplantation: a retrospective study from the Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC).

Transplantation and cellular therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us